These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3302344)

  • 1. [Clinical trial of forphenicinol for the lung infection with Mycobacterium avium, Mycobacterium intracellulare complex].
    Ishibashi T; Takamoto M; Shinoda A; Kihara H; Nagano H; Kawakami K; Yamato Y; Nakanishi K; Yamamoto T; Otsu T
    Jpn J Antibiot; 1987 Apr; 40(4):711-26. PubMed ID: 3302344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fundamental and clinical studies on forphenicinol, a small-molecular immunomodulator].
    Ishibashi T; Takamoto M; Shinoda A; Sugiyama K
    Jpn J Antibiot; 1984 Feb; 37(2):185-97. PubMed ID: 6737689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China.
    Zhang Z; Pang Y; Wang Y; Cohen C; Zhao Y; Liu C
    Int J Antimicrob Agents; 2015 May; 45(5):491-5. PubMed ID: 25795316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
    Miwa S; Shirai M; Toyoshima M; Shirai T; Yasuda K; Yokomura K; Yamada T; Masuda M; Inui N; Chida K; Suda T; Hayakawa H
    Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical study of clarithromycin for pulmonary Mycobacterium avium-intracellulare complex infection].
    Yamamoto M; Kuze F; Sakatani M; Saito H; Shimoide H; Soejima R; Hara K
    Kekkaku; 1997 Jan; 72(1):1-7. PubMed ID: 9038009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental chemotherapy in chronic Mycobacterium avium-intracellulare infection of mice.
    Kuze F
    Am Rev Respir Dis; 1984 Mar; 129(3):453-9. PubMed ID: 6703503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ofloxacin in the treatment of pulmonary changes caused by Mycobacterium avium and Mycobacterium xenopii].
    Zwoliński J; Gałazka J
    Pneumonol Alergol Pol; 1992; 60(5-6):70-3. PubMed ID: 1290992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Clinical features and course in 100 consecutive cases.
    Rosenzweig DY
    Chest; 1979 Feb; 75(2):115-9. PubMed ID: 421545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
    Masur H; Tuazon C; Gill V; Grimes G; Baird B; Fauci AS; Lane HC
    J Infect Dis; 1987 Jan; 155(1):127-9. PubMed ID: 3794396
    [No Abstract]   [Full Text] [Related]  

  • 10. Surgical management of pulmonary disease due to Mycobacterium avium-intracellulare.
    Corpe RF
    Rev Infect Dis; 1981; 3(5):1064-7. PubMed ID: 7339805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features of the lung diseases due to Mycobacterium avium and M. intracellulare].
    Toyoda T; Aoyagi T; Saito H
    Kekkaku; 1993 Jan; 68(1):63-9. PubMed ID: 8437427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nontuberculous mycobacterial infections of the lung].
    Latshang TD; Lo Cascio CM; Russi EW
    Ther Umsch; 2011 Jul; 68(7):402-6. PubMed ID: 21728159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
    J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
    Ye JJ; Wu TS; Chiang PC; Lee MH
    J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
    Ogawa K; Sano C
    Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relations between clinical subtypes of Mycobacterium avium pulmonary disease and polyclonal infections detected by IS1245 based restriction fragment length polymorphism analysis].
    Kuwabara K; Watanabe Y; Wada K; Tsuchiya T
    Kekkaku; 2004 Feb; 79(2):39-46. PubMed ID: 15031998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease.
    Philley JV; Wallace RJ; Benwill JL; Taskar V; Brown-Elliott BA; Thakkar F; Aksamit TR; Griffith DE
    Chest; 2015 Aug; 148(2):499-506. PubMed ID: 25675393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of infection by nontuberculous mycobacteria. VI. Identification and use of epidemiologic markers for studies of Mycobacterium avium, M. intracellulare, and M. scrofulaceum.
    Fry KL; Meissner PS; Falkinham JO
    Am Rev Respir Dis; 1986 Jul; 134(1):39-43. PubMed ID: 3729160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A clinical experience of DNA probe method for identifying Mycobacterium avium and Mycobacterium intracellulare].
    Tsuda M; Oishi N; Saeki A; Ogawa K; Honda K; Sasamoto M; Michihiro H; Miwa T
    Kekkaku; 1995 Jun; 70(6):369-76. PubMed ID: 7630072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Mycobacterium xenopi in human disease.
    Simor AE; Salit IE; Vellend H
    Am Rev Respir Dis; 1984 Mar; 129(3):435-8. PubMed ID: 6703502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.